Archivio Istituzionale della RicercaJIMENEZ MORO, JOSE LUIS
JIMENEZ MORO, JOSE LUIS
Dipartimento di Scienze Matematiche
José L. Jiménez
039664
Mostra
records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.027 secondi).
A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages
2023 Jiménez, José L; Zheng, Haiyan
Stratified modestly weighted log-rank tests in settings with an anticipated delayed separation of survival curves
2023 Dominic, Magirr; Jiménez, José L.
Combining cytotoxic agents with continuous dose levels in seamless phase I-II clinical trials
2022 Jiménez, José L.; Tighiouart, Mourad
Design and analysis of group-sequential clinical trials based on a modestly weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidance
2022 Dominic, Magirr; JIMENEZ MORO, JOSE LUIS
Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value?
2022 Tighiouart, M.; Jimenez, J. L.; Diniz, M. A.; Rogatko, A.
Quantifying treatment differences in confirmatory trials under non-proportional hazards
2022 JIMENEZ MORO, JOSE LUIS
A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching
2021 JIMENEZ MORO, JOSE LUIS; Julia, Niewczas; Alexander, Bore; Carl-Fredrik, Burman
Designs of Early Phase Cancer Trials with Drug Combinations
2021 JIMENEZ MORO, JOSE LUIS; Marcio Augusto Diniz, ; Rogatko, Andre; Tighiouart, Mourad
A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations.
2020 JIMENEZ MORO, JOSE LUIS; Kim, Sungjin; Tighiouart, Mourad
Response to comments on “Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects” by José L. Jiménez, Viktoriya Stalbovskaya and Byron Jones, Pharmaceutical Statistics, 2019; 18:287-303, DOI: 10.1002/pst.1923
2020 JIMENEZ MORO, JOSE LUIS; Stalbovskaya, Viktoriya; Jones, Byron
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents
2019 JIMENEZ MORO, JOSE LUIS; Tighiouart, Mourad; Gasparini, Mauro
Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects
2019 Jimenez, Jose L.; Viktoriya, Stalbovskaya; Byron, Jones
Innovative adaptive designs in oncology clinical trials with drug combinations
2018 Jimenez, Jose L.
| Citazione | Data di pubblicazione | Autori | File |
|---|---|---|---|
| A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages / Jiménez, José L; Zheng, Haiyan. - In: BIOMETRICAL JOURNAL. - ISSN 0323-3847. - (2023). [10.1002/bimj.202200288] | 1-gen-2023 | Jiménez, José L + | Jimenez and Zheng (2023).pdf |
| Stratified modestly weighted log-rank tests in settings with an anticipated delayed separation of survival curves / Dominic, Magirr; Jiménez, José L.. - In: BIOMETRICAL JOURNAL. - ISSN 1521-4036. - (2023). [10.1002/bimj.202200126] | 1-gen-2023 | José L. Jiménez + | 17615254.pdf |
| Combining cytotoxic agents with continuous dose levels in seamless phase I-II clinical trials / Jiménez, José L.; Tighiouart, Mourad. - In: JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS. - ISSN 0035-9254. - 71:5(2022), pp. 1996-2013. [10.1111/rssc.12598] | 1-gen-2022 | José L. Jiménez + | Jimenez and Tighiouart 2022 JRSS C preprint.pdf; Combining cytotoxic agents with continuous dose levels in seamless phase I‐II clinical trials.pdf |
| Design and analysis of group-sequential clinical trials based on a modestly weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidance / Dominic, Magirr; JIMENEZ MORO, JOSE LUIS. - In: CLINICAL TRIALS. - ISSN 1740-7745. - 19:2(2022), pp. 201-210. [10.1177/17407745211072848] | 1-gen-2022 | Jose Luis Jiménez Moro + | 2022b - Design and analysis of GS clinical trials based on modestly-weight LR.pdf |
| Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value? / Tighiouart, M.; Jimenez, J. L.; Diniz, M. A.; Rogatko, A.. - In: BRAZILIAN JOURNAL OF BIOMETRICS. - ISSN 2764-5290. - 40:4(2022), pp. 453-468. [10.28951/bjb.v40i4.627] | 1-gen-2022 | Jimenez J. L. + | Thigourad_etal_627.pdf |
| Quantifying treatment differences in confirmatory trials under non-proportional hazards / JIMENEZ MORO, JOSE LUIS. - In: JOURNAL OF APPLIED STATISTICS. - ISSN 0266-4763. - 49:2(2022), pp. 466-484. [10.1080/02664763.2020.1815673] | 1-gen-2022 | Jose Luis Jimenez | 1908.10502.pdf; Quantifying treatment differences in confirmatory trials under non proportional hazards.pdf |
| A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching / JIMENEZ MORO, JOSE LUIS; Julia, Niewczas; Alexander, Bore; Carl-Fredrik, Burman. - In: PLOS ONE. - ISSN 1932-6203. - 16:11(2021), pp. 1-22. [10.1371/journal.pone.0259178] | 1-gen-2021 | José Luis Jiménez + | journal.pone.0259178.pdf |
| Designs of Early Phase Cancer Trials with Drug Combinations / JIMENEZ MORO, JOSE LUIS; Marcio Augusto Diniz, ; Rogatko, Andre; Tighiouart, Mourad - In: Modern Statistical Methods for Health Research[s.l] : Springer International Publishing, 2021. - ISBN 978-3-030-72437-5. - pp. 131-160 [10.1007/978-3-030-72437-5_7] | 1-gen-2021 | Jose Luis Jimenez + | 2021_Book_ModernStatisticalMethodsForHea.pdf; 10.1007_978-3-030-72437-5_7.pdf |
| A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations / JIMENEZ MORO, JOSE LUIS; Kim, Sungjin; Tighiouart, Mourad. - In: BIOMETRICAL JOURNAL. - ISSN 1521-4036. - ELETTRONICO. - 62:5(2020), pp. 1300-1314. [10.1002/bimj.201900095] | 1-gen-2020 | Jose Luis Jimenez Moro + | bimj.201900095.pdf |
| Response to comments on “Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects” by José L. Jiménez, Viktoriya Stalbovskaya and Byron Jones, Pharmaceutical Statistics, 2019; 18:287-303, DOI: 10.1002/pst.1923 / JIMENEZ MORO, JOSE LUIS; Stalbovskaya, Viktoriya; Jones, Byron. - In: PHARMACEUTICAL STATISTICS. - ISSN 1539-1604. - ELETTRONICO. - 19:5(2020), pp. 736-740. [10.1002/pst.2021] | 1-gen-2020 | Jose Luis Jimenez Moro + | Jimenez et al. .pdf |
| Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents / JIMENEZ MORO, JOSE LUIS; Tighiouart, Mourad; Gasparini, Mauro. - In: BIOMETRICAL JOURNAL. - ISSN 0323-3847. - (2019). [10.1002/bimj.201700166] | 1-gen-2019 | JIMENEZ MORO, JOSE LUISGasparini, Mauro + | Jimenez_preprint.pdf |
| Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects / Jimenez, Jose L.; Viktoriya, Stalbovskaya; Byron, Jones. - In: PHARMACEUTICAL STATISTICS. - ISSN 1539-1604. - ELETTRONICO. - 18:3(2019), pp. 287-303. [10.1002/pst.1923] | 1-gen-2019 | Jose L. Jimenez + | 1806.11294-2.pdf; Properties of the weighted log‐rank test in the design of confirmatory studies with delayed effects.pdf |
| Innovative adaptive designs in oncology clinical trials with drug combinations / Jimenez, Jose L.. - (2018). | 1-gen-2018 | Jose L. Jimenez | PhD-Thesis-Jimenez.pdf |